Skip to main content
. 2019 Feb 28;14(2):e0212909. doi: 10.1371/journal.pone.0212909

Fig 6. The recombinant YfdX exhibits a chaperone activity.

Fig 6

(A) Samples containing ADH and the recombinant His6-YfdX were subjected to pH 1.0 treatment and then their OD400 were measured. The decreasing optical density corresponds to more aggregated protein formed in the solution. (B) Samples containing ADH and the recombinant His6-YfdX were subjected to treatment for 15 min at pH 1.0 or 7.0, and the insoluble aggregated proteins were removed. The supernatant fractions containing soluble protein were analyzed by SDS-PAGE.